94 related articles for article (PubMed ID: 1653558)
1. [Intrapleural administration of pirarubicin in the treatment of malignant pleural effusion].
Gotoh T; Nakamura T; Hiramori N; Fujii T; Fujita Y; Kida T; Arimoto T; Sakai M; Iwasaki Y; Tanaka Y
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2121-7. PubMed ID: 1653558
[TBL] [Abstract][Full Text] [Related]
2. [Local administration of adriamycin (ADM) for malignant pleural effusion and pericardiac effusion in breast cancer].
Saisho S; Saeki T; Takashima S; Aogi K; Ohsumi S
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2063-8. PubMed ID: 14712766
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of intrapleural administration of pirarubicin (THP-ADM) in the treatment of malignant pleural effusion secondary to lung cancer].
Makimoto T; Hoshino H; Tsuchiya S; Nakano H; Watanabe S; Naruse I; Fueki N; Ezawa K; Takise A; Saitoh R
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1542-7. PubMed ID: 8121090
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
5. Intrapleural pirarubicin (4'-O-tetrahydropyranyladriamycin) for treatment of malignant pleural effusion.
Gotoh T; Tanaka Y; Fujita Y; Hiramori N; Fujii T; Arimoto T; Iwasaki Y; Fukabori T; Nakamura T; Ono N; Nakagawa M
Jpn J Clin Oncol; 1996 Oct; 26(5):328-34. PubMed ID: 8895673
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of carboplatin administration into the serous cavity in the treatment of malignant effusion].
Gotoh T; Hiramori N; Fujita Y; Fujii T; Kida T; Sakai M; Arimoto T; Iwasaki Y; Nakamura T; Nakagawa M
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1790-4. PubMed ID: 1877819
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
8. [Intrapleural bleomycin for management of malignant pleural effusions].
Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Furuta H; Inui H; Fujimoto H
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1203-7. PubMed ID: 7544964
[TBL] [Abstract][Full Text] [Related]
9. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
10. [Intrapleural DDP and systemic thiosulfate rescue in the treatment of malignant pleural effusion].
Hua X; Lu W; Duan G
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):50-2. PubMed ID: 7656790
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
Kang M; Zhou L; Lin P
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
[TBL] [Abstract][Full Text] [Related]
12. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
14. [Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
Shimizu E; Saijo N; Shinkai T; Eguchi K; Tominaga K; Nomori H; Sasaki Y; Garcia-Herreros P; Hoshi A
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1290-5. PubMed ID: 6732255
[TBL] [Abstract][Full Text] [Related]
15. [A case of malignant pericardial effusion due to breast cancer successfully controlled by intrapericardial chemotherapy using pirarubicin].
Fujito T; Maeura Y; Shimoda M; Hojo S; Yano Y; Matsunaga S
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1757-9. PubMed ID: 11708027
[TBL] [Abstract][Full Text] [Related]
16. [Serratia marcescens vaccine in the treatment of malignant pleural effusion].
Shi H; Zhu Y; Xu L; Liu Z; You Y; Meng Q; Zhang X; Xu J
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):188-90. PubMed ID: 12015046
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of malignant pleural effusion using vindesine and cisplatine intrapleurally injection (observation of 60 cases)].
Zhang Z; Li D; Wu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):29-31. PubMed ID: 11802935
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
[TBL] [Abstract][Full Text] [Related]
19. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion.
Muraoka M; Oka T; Akamine S; Tagawa T; Morinaga M; Inoue M; Yamayoshi T; Hashizume S; Matsumoto K; Hayashi T; Nagayasu T
J Surg Oncol; 2006 Mar; 93(4):323-9. PubMed ID: 16496367
[TBL] [Abstract][Full Text] [Related]
20. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
Wakui A; Yokoyama M; Konno K; Nakai Y; Sakano T; Koyama Y; Imamura Y; Nakajima O; Niijima T; Akaza H
Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
